Resultados: 7

Long-term outcomes of second-generation drug-eluting stents versus coronary artery bypass graft: a sistematic review and meta-analysis

Circulation; 148 (Suppl.1), 2023
INTRODUCTION: Long-term data is limited on the comparative outcomes of percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (S-DES) versus coronary artery bypass grafting (CABG) in patients with coronary artery disease (CAD). Hypothesis: Our aim was to conduct a systematic...

P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial

EuroIntervention; 19 (4), 2023
Dual antiplatelet therapy (DAPT) is currently the standard of care after percutaneous coronary intervention (PCI). Recent studies suggest that reducing DAPT to 1-3 months followed by an aspirin-free single antiplatelet therapy (SAPT) strategy with a potent P2Y12 inhibitor is safe and associated with less...

Impacto da seleção para participar de um estudo randomizado no perfil clínico/angiográfico e nos resultados: hospitalares de pacientes diabéticos submetidos à intervenção coronária percutânea
Impact of selection to participate in a randomized study on the clinical/angiographic profile and results: hospital admissions of diabetic patients undergoing percutaneous coronary intervention

J. Transcatheter Interv; 31 (supl.1), 2023
INTRODUÇÃO: Em geral, pacientes (p) incluídos em estudos randomizados são selecionados e exibem perfil clínico/angiográfico de menor gravidade do que os do mundo real. Na última década, ensaios clínicos envolvendo intervenções coronárias percutâneas (ICP) com novos modelos de stents farmacol...

Impact of stent diameter on clinical outcomes following percutaneous coronary intervention with thirdgeneration drug-eluting stents: results from inspirion and latitude trials

J. Transcatheter Interv; 31 (supl.1), 2023
INTRODUCTION: In patients treated with bare metal stents and earlygeneration drug-eluting stents (DES) smaller stent diameter (SD) has been associated with worse long-term outcomes after percutaneous coronary intervention (PCI). Data on the impact of small SD on outcomes after PCI with third generation D...

Experiência inicial com o uso de balão farmacológico em pacientes de hospital terciário do sistema único de saúde
Initial experience with the use of drug-eluting balloons in patients at a tertiary hospital in the Unified Health System

J. Transcatheter Interv; 31 (supl.1), 2023
FUNDAMENTOS: Os balões farmacológicos representam uma alternativa aos stents farmacológicos a realização de intervenção coronária percutânea (ICP). São dispositivos capazes de entrega de droga anti- -proliferativa na lesão-alvo de forma homogênea, com a vantagem da ausência de suporte metál...

Revascularização percutânea em mulheres e seus resultados: de mundo real
Percutaneous revascularization in women and its results: real world

J. Transcatheter Interv; 31 (supl.1), 2023
INTRODUÇÃO: As doenças cardiovasculares (DCV) são a principal causa de morte e incapacidade do mundo há mais de duas décadas, sendo responsáveis por mais de um terço das mortes globalmente. A compreensão da DCV no sexo feminino ainda apresenta lacunas visto que, mulheres são sub-representadas e...

Bioresorbable polymer Sirolimus-Eluting stent in native coronary artery stenosis: results of the prospective, multicenter inspirion and latitude trials

J. Transcatheter Interv; 31 (supl.1), 2023
INTRODUCTION: Inspiron® (Scitech, Brazil) is a 3rd generation drug eluting stent designed to create a fast and homogeneous endothelialization, possibly improving clinical outcomes. OBJECTIVES: The aim of this study was to evaluate the safety and efficacy of a sirolimus-eluting coronary stent, composed o...